Economic burden of back and neck pain: Effect of a neuropathic component

Population Health Management

Volumn 17, Issue 4, 2014, Pages 224-232

  Kleinman, Nathan ^a   Patel, Aarti A ^b   Benson, Carmela ^b   Macario, Alex ^c   Kim, Myoung ^b   Biondi, David M ^b  

^a Human Capital Management Services   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; BACKACHE; CONTROLLED STUDY; COST OF ILLNESS; ECONOMIC ASPECT; EMPLOYEE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK PAIN; NEURITIS; NEUROPATHIC PAIN; NOCICEPTIVE PAIN; PRESCRIPTION; PRODUCTIVITY; RADICULITIS; SPINAL CORD COMPRESSION; SPINAL CORD DISEASE; TURNOVER TIME; WORK DISABILITY; WORKMAN COMPENSATION; BACK PAIN; COMORBIDITY; COMPLICATION; ECONOMICS; EMPLOYMENT; FACTUAL DATABASE; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL LEAVE; NEURALGIA; RETROSPECTIVE STUDY; STATISTICAL MODEL; UNITED STATES;

ANALGESIC AGENT;

ADULT; ANALGESICS; BACK PAIN; COMORBIDITY; COST OF ILLNESS; DATABASES, FACTUAL; EFFICIENCY; EMPLOYMENT; FEMALE; HEALTH EXPENDITURES; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; NECK PAIN; NEURALGIA; RETROSPECTIVE STUDIES; SICK LEAVE; UNITED STATES;

EID: 84906275069     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2013.0071     Document Type: Article

References (33)

1. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5:143-149.
2. Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep 2009;13:185-190.
3. Manca A, Kumar K, Taylor RS, et al. Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). Eur J Pain 2008;12:1047-1058.
4. Wand BM, O'Connell NE. Chronic non-specific low back pain-sub-groups or a single mechanism? BMC Musculoskelet Disord 2008;9:11.
5. Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 2010;149:338-344.
6. Galvez R,Marsal C, Vidal J, RuizM, Rejas J. Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions. Eur J Pain 2007;11:244-255.
7. Haanpaa ML, Backonja MM, Bennett MI, et al. Assessment of neuropathic pain in primary care. Am J Med 2009; 122(10 suppl):S13-S21.
8. Parker SL, Xu R, McGirt MJ, Witham TF, Long DM, Bydon A. Long-term back pain after a single-level discectomy for radiculopathy: incidence and health care cost analysis. J Neurosurg Spine 2010;12:178-182.
9. Taylor RS. Epidemiology of refractory neuropathic pain. Pain Pract 2006;6:22-26.
10. Schmidt CO, Schweikert B, Wenig CM, et al. Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain 2009;13: 1030-1035.
11. Hoy D, March L, Brooks P, et al. Measuring the global burden of low back pain. Best Pract Res Clin Rheumatol 2010;24:155-165.
12. Rodriguez MJ, Garcia AJ. A registry of the aetiology and costs of neuropathic pain in pain clinics: results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study. Clin Drug Investig 2007;27:771-782.
13. Crow WT, Willis DR. Estimating cost of care for patients with acute low back pain: a retrospective review of patient records. J Am Osteopath Assoc 2009;109:229-233.
14. White AG, Birnbaum HG, Mareva MN, Henckler AE, Grossman P, Mallett DA. Economic burden of illness for employees with painful conditions. J Occup Environ Med 2005;47:884-892.
15. Brook RA, Kleinman NL, Patel PA, et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006;22:1381-1389.
16. Brook RA, Wahlqvist P, Kleinman NL, Wallander MA, Campbell SM, Smeeding JE. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States. Aliment Pharmacol Ther 2007;26:889-898.
17. Gardner HH, Kleinman NL, Brook RA, Rajagopalan K, Brizee TJ, Smeeding JE. The economic impact of bipolar disorder in an employed population from an employer perspective. J Clin Psychiatry 2006;67:1209-1218.
18. Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health 2007;10:231-237.
19. Kleinman NL, Brook RA, Rajagopalan K, Gardner HH, Brizee TJ, Smeeding JE. Lost time, absence costs, and reduced productivity output for employees with bipolar disorder. J Occup Environ Med 2005;47:1117-1124.
20. Kleinman NL, Melkonian A, Borden S, Rohrbacker N, Lynch WD, Gardner HH. The impact of morbid obesity and bariatric surgery on comorbid conditions: a comprehensive examination of comorbidities in an employed population. J Occup Environ Med 2009;51:170-179.
21. Rohrbacker NJ, Kleinman NL, White SA, March JL, Reynolds MR. The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: associated costs, absences, and objective productivity loss. J Occup Environ Med 2010;52:383-391.
22. Wahlqvist P, Brook RA, Campbell SM, et al. Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease. J Occup Environ Med 2008; 50:25-31.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
24. United States Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers (Current Series). August 2009. Available at: < http://data.bls.gov/pdq/querytool.jsp?survey = cu > . Accessed January 31, 2012.
25. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ 1999;18: 153-171.
26. Cote P, van der Velde G, Cassidy JD, et al. The burden and determinants of neck pain in workers: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976) 2008;33(4 suppl):S60-S74.
27. Leigh JP, Sheetz RM. Prevalence of back pain among fulltime United States workers. Br J Ind Med 1989;46: 651-657.
28. Loeppke R, Taitel M, Haufle V, Parry T, Kessler RC, Jinnett K. Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med 2009;51:411-428.
29. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-1534.
30. Hans G, Masquelier E, De CP. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study. BMC Public Health 2007;7:170.
31. Jespersen A, Amris K, Bliddal H, et al. Is neuropathic pain underdiagnosed in musculoskeletal pain conditions? The Danish PainDETECTive study. Curr Med Res Opin 2010;26: 2041-2045.
32. McCombs JS, Ahn J, Tencer T, Shi L. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. J Affect Disord 2007;97:171-179.
33. Green PH, Neugut AI, Naiyer AJ, Edwards ZC, Gabinelle S, Chinburapa V. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med 2008;40:218-228.